菌体模型系统作为治疗剂的未开发潜力
Jordan Romeyer Dherbey1, Frederic Bertels1
1Microbial Population Biology, Max Planck Institute for Evolutionary Biology, August-Thienemann-Straße 2, Plön, Schleswig-Holstein 24306, Germany.
Virus evolution
|February 16, 2024
概括
菌体 (菌体) 显示出对抗抗生素耐药细菌的有希望. 设计精心研究的菌体来感染病原体可能会加速开发新的菌体疗法.
科学领域:
- 微生物学 微生物学
- 细菌治疗疗法是一种细菌治疗.
- 抗微生物耐药性 抗微生物耐药性
背景情况:
- 广泛的抗生素耐药性需要替代性治疗细菌感染.
- 菌体 (菌体) 是感染细菌的病毒,正在被探索作为治疗剂.
- 隔离新型菌体是成功的同情使用,但资源密集型广泛的治疗开发.
研究的目的:
- 探索使用已建立的菌体模型系统用于治疗开发的潜力.
- 为了应对模型菌体无法感染病原细菌的挑战.
- 通过扩大模型菌体宿主范围,提出开发菌体治疗方法的战略.
主要方法:
- 审查已建立的菌体模型系统的现有知识.
- 讨论基因工程和实验进化的策略,以修改菌体宿主范围.
- 分析适应模型菌体感染目标病原体的可行性.
主要成果:
- 已建立的菌体模型系统拥有广泛的研究数据,确保安全的应用和处理.
- 基因工程和进化实验可能会扩大模型菌体的宿主范围.
- 与新型菌体隔离相比,调整模型菌体提供了一个潜在的资源密集度较低的治疗开发途径.
结论:
- 已建立的菌体模型系统可以被设计成感染病原细菌,克服一个关键的限制.
- 培育模型菌体以向特定的病原体是开发有效菌体治疗方法的有希望的未来途径.
- 这种方法可以显著减少菌体治疗开发所需的时间和财务投资.
相关概念视频
Lytic Cycle of Bacteriophages
70.7K
Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the...
70.7K
Lysogenic Cycle of Bacteriophages
62.2K
In contrast to the lytic cycle, phages infecting bacteria via the lysogenic cycle do not immediately kill their host cell. Instead, they combine their genome with the host genome, allowing the bacteria to replicate the phage DNA along with the bacterial genome. The incorporated copy of the phage genome is called the prophage. Some prophages can re-activate and enter the lytic cycle. This often occurs in response to a perturbation, such as DNA damage, but can also transpire in the absence of...
62.2K
CRISPR and crRNAs
17.0K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
17.0K


